Cancer cells regulate the expression levels of immune checkpoints and inhibit killing effects of host immune systems, so genes regarding the immune checkpoints, including PD-L1 [17] and CD47 [18] have become potential targets for cancer immunotherapies. This evidence concerns the gene CD274 and cancer.